Cargando…
Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension
BACKGROUND: Autosomal dominant inheritance of germline mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene are a major risk factor for pulmonary arterial hypertension (PAH). While previous studies demonstrated a difference in severity between BMPR2 mutation carriers and noncarri...
Autores principales: | Austin, Eric D, Phillips, John A, Cogan, Joy D, Hamid, Rizwan, Yu, Chang, Stanton, Krista C, Phillips, Charles A, Wheeler, Lisa A, Robbins, Ivan M, Newman, John H, Loyd, James E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762975/ https://www.ncbi.nlm.nih.gov/pubmed/19785764 http://dx.doi.org/10.1186/1465-9921-10-87 |
Ejemplares similares
-
Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance
por: West, James, et al.
Publicado: (2008) -
Abnormal Trafficking of Endogenously Expressed BMPR2 Mutant Allelic Products in Patients with Heritable Pulmonary Arterial Hypertension
por: Frump, Andrea L., et al.
Publicado: (2013) -
Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension
por: Johnson, Jennifer A, et al.
Publicado: (2009) -
BMPR2 expression is suppressed by signaling through the estrogen receptor
por: Austin, Eric D, et al.
Publicado: (2012) -
The genetics of pulmonary arterial hypertension in the post-BMPR2 era
por: Fessel, Joshua P., et al.
Publicado: (2011)